Shannon Morris - Feb 5, 2024 Form 4 Insider Report for Erasca, Inc. (ERAS)

Role
Chief Medical Officer
Signature
/s/ Ebun Garner, attorney-in-fact
Stock symbol
ERAS
Transactions as of
Feb 5, 2024
Transactions value $
$0
Form type
4
Date filed
2/7/2024, 06:48 PM
Previous filing
Apr 13, 2023
Next filing
Jun 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERAS Stock Option (right to buy) Award $0 +536K $0.00 536K Feb 5, 2024 Common Stock 536K $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.